| MR编号 | AT/H/1318/001 |
|---|
| 药品名称 | Eisen-Carboxymaltose ratiopharm 50 mg/ml Dispersion zur Injektion/Infusion |
|---|
| 活性成分 | - ferric carboxymaltose 50.0 mg/ml
|
|---|
| 剂型 | Dispersion for injection/infusion |
|---|
| 上市许可持有人 | Teva B.V.
Swensweg 5
2031GA Haarlem
Netherlands |
|---|
| 参考成员国 - 产品名称 | Austria (AT) |
|---|
| 互认成员国 - 产品名称 | - Norway (NO)
- Hungary (HU)
- Germany (DE)
Ferric Carboxymaltose ratiopharm 50 mg/ml Injektions-/Infusionslösung - Bulgaria (BG)
Maxifer - Denmark (DK)
- Czechia (CZ)
Ferric carboxymaltose Teva - Netherlands (NL)
IJzer(III)carboxymaltose Teva 50 mg/ml, dispersie voor injectie/infusie - Romania (RO)
Carboximaltoză ferică Teva 50 mg/ml soluție injectabilă/perfuzabilă - Ireland (IE)
- Slovakia (SK)
- France (FR)
- Slovenia (SI)
- Spain (ES)
- Croatia (HR)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
|
|---|
| 许可日期 | 2024/02/15 |
|---|
| 最近更新日期 | 2024/03/20 |
|---|
| 药物ATC编码 | - B03AC Iron, parenteral preparations
| 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|